首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Analytical Quality of Near-Patient Blood Cholesterol and Glucose Determinations
【24h】

Analytical Quality of Near-Patient Blood Cholesterol and Glucose Determinations

机译:近患者胆固醇的分析质量和血糖测定

获取原文
           

摘要

Background: Screening for diabetes and hypercholesterolemia is widely advocated, and extra-laboratory testing could play a major role in cost-effective population screening. We wished to assess the analytical quality and interchangeability of capillary blood cholesterol and glucose assays as performed on near-patient devices in pharmacies in Pretoria, South Africa.Methods: Accuracy of near-patient and laboratory analyzers was assessed by analyses of human-serum-based reference material. To assess interchangeability in routine use, six volunteers visited each of 12 randomly selected pharmacies consecutively during a 3-week period to have their fasting blood glucose and cholesterol concentrations determined. For comparison purposes, a similar procedure was followed to evaluate the eight clinical chemistry laboratories servicing Pretoria and surroundings.Results: The analytical performances in our laboratory of a single point-of-care instrument and of a laboratory analyzer compared well. Nevertheless, between-pharmacy analytical variation was larger than between-laboratory variation (11% vs 6.1% for cholesterol; 10% vs 7.6% for glucose). For glucose measurements, near-patient testing in pharmacies demonstrated a bias of ?48.1% to 16.2%, whereas bias for laboratory measurements was ?1.0% to 7.4%. Cholesterol assays showed a bias of ?5.6% to 16.6% in pharmacies compared with ?10.6% to 3.7% in laboratories. The percentage of closeness to the homeostatic set point for a single glucose and cholesterol determination done in any pharmacy was 24.6% and 23.6%, respectively. The corresponding values for laboratories were 16.9% and 15.6%, respectively.Conclusions: Although modern point-of-care instruments allow high-quality blood analyses under ideal conditions, performance goals often are not achieved in practice as indicated by a higher uncertainty of cholesterol and glucose blood results when determined in pharmacies. Nonuniformity of calibration procedures, deficiencies in training, a lack of internal quality control, and the absence of an external quality assessment program may all contribute to the current state of affairs.
机译:背景:广泛提倡对糖尿病和高胆固醇血症进行筛查,实验室外检测可能在具有成本效益的人群筛查中发挥重要作用。我们希望评估在南非比勒陀利亚的药房中对近端设备进行的毛细血管胆固醇和葡萄糖测定的分析质量和互换性。方法:近端分析仪和实验室分析仪的准确性通过对人血清的分析进行评估。基础参考资料。为了评估常规使用中的互换性,六名志愿者在3周的时间内连续访问了12家随机选择的药房,以测定其空腹血糖和胆固醇浓度。为了进行比较,采用了类似的程序来评估为比勒陀利亚和周围环境提供服务的8个临床化学实验室。结果:在我们实验室中,单一现场护理仪器和实验室分析仪的分析性能进行了比较。不过,药房间的分析差异大于实验室间的差异(胆固醇的11%比6.1%;葡萄糖的10%比7.6%)。对于葡萄糖测量,在药房进行的近距离测试显示偏倚约为48.1%至16.2%,而实验室测量偏倚约为1.0%至7.4%。胆固醇测定显示,药房的偏差为5.6%至16.6%,而实验室的偏差为10.6%至3.7%。在任何一家药房中进行一次葡萄糖和胆固醇测定时,均接近稳态设定点的百分比分别为24.6%和23.6%。结论:尽管现代的现场护理仪器可以在理想的条件下进行高质量的血液分析,但实际操作中通常无法实现性能目标,因为胆固醇的不确定性较高当在药店确定血糖和血糖结果时。校准程序的不统一,培训的不足,缺乏内部质量控制以及缺乏外部质量评估程序都可能导致当前的状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号